Sivik Global Healthcare LLC boosted its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 11.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 50,000 shares of the company's stock after buying an additional 5,000 shares during the quarter. Cardinal Health makes up about 3.1% of Sivik Global Healthcare LLC's holdings, making the stock its 11th biggest position. Sivik Global Healthcare LLC's holdings in Cardinal Health were worth $5,914,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. State Street Corp increased its stake in shares of Cardinal Health by 4.6% in the third quarter. State Street Corp now owns 14,177,641 shares of the company's stock worth $1,566,913,000 after purchasing an additional 627,253 shares during the period. Two Sigma Advisers LP grew its holdings in Cardinal Health by 47.9% in the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company's stock valued at $118,197,000 after buying an additional 346,362 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec increased its position in Cardinal Health by 230.0% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company's stock worth $52,819,000 after buying an additional 333,095 shares during the period. Wedge Capital Management L L P NC bought a new stake in shares of Cardinal Health in the third quarter valued at approximately $30,820,000. Finally, Worldquant Millennium Advisors LLC grew its stake in shares of Cardinal Health by 77.3% in the third quarter. Worldquant Millennium Advisors LLC now owns 593,007 shares of the company's stock worth $65,539,000 after acquiring an additional 258,541 shares during the last quarter. Institutional investors own 87.17% of the company's stock.
Cardinal Health Price Performance
Shares of CAH traded up $2.28 on Monday, hitting $125.94. The company's stock had a trading volume of 2,054,525 shares, compared to its average volume of 2,364,934. The company has a market capitalization of $30.42 billion, a PE ratio of 23.50, a PEG ratio of 1.46 and a beta of 0.63. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $132.84. The company has a 50 day moving average price of $122.03 and a 200 day moving average price of $114.32.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, equities analysts forecast that Cardinal Health, Inc. will post 7.92 EPS for the current year.
Cardinal Health Cuts Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were paid a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.61%. The ex-dividend date of this dividend was Thursday, January 2nd. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.
Analyst Ratings Changes
CAH has been the subject of several research analyst reports. Bank of America upgraded shares of Cardinal Health from a "neutral" rating to a "buy" rating and upped their target price for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Barclays increased their target price on shares of Cardinal Health from $117.00 to $133.00 and gave the company an "overweight" rating in a research note on Monday, November 4th. Mizuho assumed coverage on Cardinal Health in a research note on Wednesday, December 4th. They set an "outperform" rating and a $139.00 price target on the stock. Wells Fargo & Company raised their price objective on Cardinal Health from $127.00 to $135.00 and gave the stock an "equal weight" rating in a research report on Wednesday, January 29th. Finally, Citigroup boosted their price objective on Cardinal Health from $120.00 to $129.00 and gave the company a "neutral" rating in a research report on Friday, January 10th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $135.64.
Get Our Latest Report on CAH
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
